The Magazine for Sleep Professionals
Friday, November 6, 2026
Zoll® announced that transvenous phrenic nerve stimulation (TPNS) – the treatment currently available only by the ZOLL remedē System – is now included in the updated American Academy of Sleep Medicine (AASM) guidelines for treatment of central sleep apnea (CSA). The AASM recognizes the patient benefits of TPNS, highlighting the […]
During Down Syndrome Awareness Month, Joe DiMaggio Children’s Hospital is celebrating its first successful implantation of an Inspire hypoglossal nerve stimulation device in a teenage patient with Down syndrome and obstructive sleep apnea. “For families whose children have Down syndrome and continue to struggle with sleep apnea despite surgery or […]
Out of my 25 years as a certified physician assistant, I’ve spent 15 working in sleep medicine. For much of that time, I’ve had a burr under my saddle. What is that burr? It’s that sleep medicine is not simply sleep apnea medicine. There are approximately 80 or so sleep […]
ZOLL® announced that PolySenseTM, a new set of accessories that expands the WatchPAT® 400 from a standard home sleep apnea test (HSAT) to home polysomnography (home PSG), has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). Built from customer feedback, PolySense is designed for simplicity, scalability and speed. Easy […]
Specialists in sleep medicine are attuned to the tip of the sleep apnea iceberg: The middle-aged overweight man with a thick neck and a partner describing snoring and pauses in his breathing. This is the slam-dunk patient who creates so much job satisfaction, with a clear diagnosis and often a […]
Resmed announced the U.S. launch of AirTouch F40, the newest addition to its growing portfolio of fabric continuous positive airway pressure (CPAP) masks. Designed for people with obstructive sleep apnea (OSA) to provide greater comfort and choice in therapy1, the AirTouch F40 helps address key factors that can influence long-term […]
My training for positive airway pressure (PAP) setup started with a few days of shadowing another employee at the durable medical equipment (DME) supplier where I worked. After that, I was handed a script to follow and a list of boxes to check during every setup. It covered how the […]
Mosanna Therapeutics, Inc., announced results from its Phase 1 MOSAIC study. MOS118 was safe and well tolerated across all doses, with no serious adverse events reported. These results support progression of the study into patients with OSA. “With these results we can now proceed to evaluate MOS118 in the patients it […]
Inspire Medical Systems, Inc. announced that the American Medical Association (AMA) CPT® Editorial Panel has approved the establishment of a new set of Current Procedural Terminology (CPT®) codes that accurately describe and include the Inspire V system. The new Category I codes are scheduled to take effect on January 1, […]
Lilly announced detailed results from TRIUMPH-2, a Phase 3 trial evaluating the efficacy and safety of retatrutide, an investigational, first-in-class GIP, GLP-1, and glucagon triple hormone receptor agonist, in adults with type 2 diabetes and obesity or overweight. At 80 weeks, all doses of retatrutide (4 mg, 9 mg, and […]
